New technologies and advances in weight loss therapy.

Nuevas tecnologías y avances en terapias para la pérdida de peso.
Balón gástrico. Bariatric endoscopy Bariatric surgery Cirugía bariátrica Endoscopic gastroplasty Endoscopía bariátrica Gastroplastia endoscópica Intragastric balloon Obesidad Obesity

Journal

Revista de gastroenterologia de Mexico (English)
ISSN: 2255-534X
Titre abrégé: Rev Gastroenterol Mex (Engl Ed)
Pays: Mexico
ID NLM: 101778603

Informations de publication

Date de publication:
Historique:
received: 01 05 2020
revised: 14 05 2020
accepted: 25 05 2020
pubmed: 10 8 2020
medline: 21 9 2021
entrez: 10 8 2020
Statut: ppublish

Résumé

Bariatric surgery is the most effective treatment for obesity and its comorbidities but there are barriers that prevent its general acceptance. The growing obesity epidemic has resulted in the need for the creation of new, less invasive treatments, with a wide margin of safety and effectiveness for conditioning weight loss, at least greater than that resulting from treatment based on diet and exercise. Emerging therapies include devices that are endoscopically placed and removed, classified as: space-occupying devices, restrictive or anatomic-remodeling procedures, endoluminal bypass, and duodenal mucosal resurfacing. Percutaneous techniques and less invasive surgeries are also included. In general, results have shown improvement in glucose metabolism in diabetic patients. With respect to weight loss, results do not surpass those of bariatric surgery, but are better than results with conservative treatment (diet and exercise) and have a low rate of adverse events. Clinical use of a new technique should be carried out within a multidisciplinary management program that includes nutritional, psychologic, physical activity, and medical support. It must be understood that novel therapies are not being created to substitute bariatric surgery, but rather to increase treatment options in the general population, with greater reach and impact. The aim of the present study was to provide an up-to-date literature review on emerging technologies for the treatment of obesity.

Identifiants

pubmed: 32768319
pii: S0375-0906(20)30081-1
doi: 10.1016/j.rgmx.2020.05.007
pii:
doi:

Types de publication

Journal Article Review

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

452-460

Informations de copyright

Copyright © 2020 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A. All rights reserved.

Auteurs

C Zerrweck (C)

Clínica Integral de Cirugía para la Obesidad y Enfermedades Metabólicas, Hospital General Tláhuac, Ciudad de México, México. Electronic address: zerrweck@yahoo.com.

O Espinosa (O)

Clínica Integral de Cirugía para la Obesidad y Enfermedades Metabólicas, Hospital General Tláhuac, Ciudad de México, México.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH